News

Barchart on MSN14h
A $1.3 Billion Reason to Buy Eli Lilly Stock Now
Eli Lilly (LLY) is a pharmaceutical company that focuses on cardiometabolic health, neuroscience, oncology, and immunology.
Zacks Investment Research on MSN19h
LLY vs. ABBV: Which Pharma Powerhouse is the Better Bet?
Eli Lilly LLY and AbbVie ABBV are U.S.-based pharmaceutical powerhouses with blockbuster drug portfolios, robust pipelines, ...
Eli Lilly says India response to obesity drug Mounjaro is 'positive', will focus on meeting demand
Eli Lilly said the response for its blockbuster drug Mounjaro has been "positive" in India, adding that it is focusing on ...
Investing Snacks1d
Why Eli Lilly’s Stock Slumped This Quarter
Eli Lilly's stock recently took a hit, leaving investors scrambling like pharmacists out of espresso. The company’s ...
Eli Lilly to Buy Gene Therapy Firm Verve in $1 Billion Deal to Develop Heart Drug
The deal, announced June 17, includes a cash offer of $10.50 per share for all outstanding Verve stock. Lilly may also pay as ...
Adam Parker of Trivariate Research Recommends Eli Lilly’s Dividend as a Defensive Play
Eli Lilly and Company (NYSE:LLY) is one of Best Dividend Stocks to Buy for Dependable Dividend Growth. According to Adam ...
Eli Lilly’s Dividend May Be Small, But its Growth Tells a Bigger Story
Eli Lilly and Company (NYSE:LLY) may offer a modest dividend yield, but its track record of consistent payouts remains strong ...
jaguarswire.usatoday10d
Lilly Diabetes' long anticipated sponsorship of Conor Daly's NASCAR debut disappears
Reed and Daly have diabetes, as does Majeski’s maternal grandfather. But when Daly took to the track Friday for Johnsonville 180 practice, it didn't have the Lilly logos and was black, green and white ...